ALPS Medical Breakthroughs ETF
SBIO
44 hedge funds and large institutions have $29.5M invested in ALPS Medical Breakthroughs ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.
13,900% more call options, than puts
Call options by funds: $280K | Put options by funds: $2K
0% more capital invested
Capital invested by funds: $29.4M → $29.5M (+$90.3K)
0.72% less ownership
Funds ownership: 30.45% → 29.74% (-0.72%)
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
15% less funds holding
Funds holding: 52 → 44 (-8)
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.52M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$304K |
| 3 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
+$164K |
| 4 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$153K |
| 5 |
LPL Financial
San Diego,
California
|
+$70.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.13M |
| 2 |
MC
Matisse Capital
Portland,
Oregon
|
-$687K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$417K |
| 4 |
Morgan Stanley
New York
|
-$362K |
| 5 |
GAM
Griffin Asset Management
New York
|
-$253K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TFS
51
TrustCore Financial Services
Brentwood,
Tennessee
| – | -$4K | -150 | Closed |
|
52
Simplex Trading
Chicago,
Illinois
| – | -$1K | -40 | Closed |
|
SBIO Hedge Fund Activity: Q3 2022 in Review
44 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2022, worth a combined $29.5M — up 0.31% from $29.4M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SBIO and 2 opened new positions — a net loss of 8 holders — while 13 trimmed existing stakes and 12 added.
The largest buyer was Susquehanna International Group, adding an estimated $1.52M. The largest seller was Bank of America, cutting an estimated $2.13M.
- 44 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2022, down from 52 in Q2 2022.
- Funds reported $29.5M of ALPS Medical Breakthroughs ETF stock for Q3 2022, up 0.31% quarter-over-quarter.
- 2 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2022 and 10 closed out, a net change of -8 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q3 2022 was Susquehanna International Group, an estimated $1.52M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q3 2022 was Bank of America, an estimated $2.13M sold.
Based on aggregated 13F filings for Q3 2022.